Table 2.
Antibiotic resistance characteristics and antibiograms of the participants admitted in 2019 and 2020.
| Parameter | 2019 (n = 105) | 2020 (n = 120) | P |
|---|---|---|---|
| Resistance to one/more antibiotics | 7/47 | 1/30 | 0.248 |
| Staphilococcus Aureus | 68 | 83 | |
| Oxacillin resistance, n (%) | 15 (22) | 34 (41) | 0.022 |
| Corinebacterium Striatum Vancomycin resistance, n (%) Linezolid resistance, n (%) |
20 14 (70) 6 (30) |
22 21 (95) 15 (68) |
0.041 0.031 |
| Enterococcus Faecalis | 20 | 13 | |
| Ampicillin resistance, n (%) | 2 (10) | 3 (23) | 0.360 |
| Enterococcus Faecium | 0 | 2 | |
| Vancomycin resistance, n (%) | 0 (0) | 0 (0) | 0.998 |
| Gram- pathogens | 67 | 75 | |
| Carbapenems resistance, n (%) | 10 (15) | 31 (41) | 0.001 |
| Colistin resistance, n (%) | 10 (18) | 37 (49) | 0.010 |
| Cephalosporins resistance, n (%) | 17 (25) | 34 (45) | 0.021 |
| Piperacillin/Tazobactam resistance, n (%) | 14 (21) | 21 (28) | 0.432 |
| Quinolones resistance, n (%) | 26 (39) | 41 (55) | 0.085 |